Clik here to view.
Kaneka Eurogentec宣布新建一家药品级生物制剂量产制造厂
比利时瑟兰 (美国商业资讯) — Kaneka Eurogentec是一家定制服务商，也是经FDA认可的合同开发和制造组织(CDMO)，该公司今天宣布，其董事会已核准在其现有工厂毗邻新建一家配置2200升发酵器的一流GMP工厂。此次扩建用于重组蛋白、抗体片段和质粒DNA等生物制剂的量产。 回应当前市场需求的新厂...
View ArticleClik here to view.
カネカユーロジェンテックが医薬品グレードバイオ医薬品の新しい大規模製造施設の建設を発表
ベルギー・セラン （ビジネスワイヤ） — カスタムサービスを提供するFDA査察済み医薬品開発製造受託機関（CDMO）のカネカユーロジェンテックは本日、現在の施設に隣接し2200 Lの発酵槽を備えた最先端GMP適合施設の新設を取締役会が承認したと発表しました。施設拡充により、組み換えタンパク質、抗体フラグメント、プラスミドDNAを含むバイオ医薬品の大規模生産が可能になります。...
View ArticleClik here to view.
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER...
NEW YORK & TOKYO Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) announced today that the Phase 3 PROSPER trial evaluating XTANDI®...
View ArticleClik here to view.
Newborn Foundation and Masimo Partnership Reaches 52,000 Babies and 1,000...
SICHUAN PROVINCE, China Masimo (NASDAQ: MASI) and the Newborn Foundation today announced that the BORN Project, their joint commitment to the United Nations’ Every Woman Every Child (EWEC)...
View ArticleClik here to view.
Toshiba Pushes Quantum Key Distribution Speed Beyond 10Mbps
TOKYO Toshiba Corporation (TOKYO:6502) and Toshiba Research Europe Limited’s Cambridge Research Laboratory in the UK have brought the enhanced security of quantum cryptography closer to practical...
View ArticleClik here to view.
H3 Biomedicine to Present New Data on H3B-6527, an FGFR4 Inhibitor, at the...
CAMBRIDGE, Mass. H3 Biomedicine Inc., a clinical stage biopharmaceutical company specializing in the discovery and development of precision medicines for oncology and a member of Eisai’s global...
View ArticleClik here to view.
Samsung Bioepis First to Receive Positive CHMP Opinion on a Trastuzumab...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on...
View ArticleClik here to view.
瑞士生产出两款用于白内障手术的创新EDOF人工晶体
瑞士纳沙泰尔 (美国商业资讯) — Swiss Advanced Vision公司(SAV-IOL SA)今天宣布上市两种用于白内障手术的新款人工晶体(IOLs) LUCIDIS和EDEN，均采用Instant Focus...
View ArticleClik here to view.
革新的なスイス製の新しい白内障手術用EDOF IOLを2種投入
スイス・ヌーシャテル （ビジネスワイヤ） — Swiss Advanced Vision（SAV-IOL SA）は本日、白内障手術用の新しい眼内レンズ（IOL）として、LUCIDISおよびEDENの2種の市場投入を発表しました。両レンズとも、特許取得済みのInstant Focus...
View ArticleClik here to view.
Cardihab Cardiac Rehab App Spun out of CSIRO eHealth Division
BRISBANE, Australia An Australian solution to dramatically improve recovery from a heart attack today became reality. Cardihab’s technology platform was developed by scientists at the Australian...
View ArticleClik here to view.
Arcus Biosciences Announces Option and License Agreement with Taiho...
HAYWARD, Calif. Arcus Biosciences, a US-based biotechnology company focused on the discovery and development of innovative cancer immunotherapies, announced today that it has entered into an option...
View ArticleClik here to view.
Eagle Pharmaceuticals Licenses Japanese Rights for Bendamustine Hydrochloride...
WOODCLIFF LAKE, N.J. & TOKYO Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) (“Eagle” or “the Company”) and SymBio Pharmaceuticals Limited (“SymBio”) (Tokyo Stock Exchange/JASDAQ 4582) today announced...
View ArticleClik here to view.
Sun Pharma Odomzo® (Sonidegib) New Label Approval Shows Sustained Duration of...
MUMBAI, India Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, “Sun Pharma” and includes its subsidiaries or associate companies) today announced...
View ArticleClik here to view.
Avita Medical and BARDA Execute a US$24.3m Contract Option
VALENCIA, Calif. & PERTH, Australia & LONDON Avita Medical (ASX: AVH) (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, today...
View ArticleClik here to view.
Exelixis Provides Update on Collaborator Daiichi Sankyo’s Phase 3 Clinical...
SOUTH SAN FRANCISCO, Calif. Exelixis, Inc. (NASDAQ: EXEL) today announced that its partner Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has reported positive top-line results from a phase 3...
View ArticleClik here to view.
Konica Minolta Accelerates Expansion of Precision Medicine Business Through...
TOKYO & BOSTON Konica Minolta, Inc. (“Konica Minolta”) (TOKYO: 4902; ISIN: JP3300600008) and Boston-based Invicro LLC (“Invicro”) today announced that they have concluded an agreement whereby...
View ArticleClik here to view.
SanBio Names Mohammad El-Kalay New Technical Operations SVP
MOUNTAIN VIEW, Calif. SanBio, Inc., a leader in regenerative cell therapies, today announced the appointment of Mohammad El-Kalay, PhD, as Senior Vice President of Technical Operations. In this...
View ArticleClik here to view.
Lombard Medical’s New Delivery System for Aorfix™ Endovascular Aortic...
OXFORDSHIRE, England Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular abdominal aortic aneurysm (AAA) endovascular repair products, today announced the...
View ArticleClik here to view.
Corindus Announces Opening of First International Robotic Training Center
WALTHAM, Mass. Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, announced today the opening of the first international CorPath GRX Robotic...
View ArticleClik here to view.
Takeda to Feature ALUNBRIG™ (brigatinib) Data from Pivotal Phase 2 ALTA Trial...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will present four company-sponsored abstracts, including one oral presentation,...
View Article